Connection

Antonio Giordano to Neoadjuvant Therapy

Back to Details
This is a "connection" page, showing publications Antonio Giordano has written about Neoadjuvant Therapy.
Antonio Giordano
Connection Strength
0.365
Neoadjuvant Therapy
  1. Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial. Int J Med Sci. 2021; 18(10):2245-2250.
    View in: PubMed
    Score: 0.176
  2. Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting. J Cell Physiol. 2018 Mar; 233(3):2313-2323.
    View in: PubMed
    Score: 0.138
  3. Circulating tumor cells in newly diagnosed inflammatory breast cancer. Breast Cancer Res. 2015 Jan 09; 17:2.
    View in: PubMed
    Score: 0.029
  4. Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy. Int J Cancer. 2012 Feb 15; 130(4):808-16.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.